Recent Posts
- Using Point-of-Care Clozapine Blood Levels to Improve Patient Management
- Pharmacists and Labs: Advancing Care
- Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines
- The Fundamentals and Role of Antipsychotic TDM in Clinical Decision Making
- Interpreting TDM Results – Interdisciplinary Collaboration for Optimized Drug Safety in Antipsychotic Therapy
-
Using Point-of-Care Clozapine Blood Levels to Improve Patient Management October 20, 2025 - Pharmacists and Labs: Advancing Care June 26, 2025
- Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines May 15, 2025
- The Fundamentals and Role of Antipsychotic TDM in Clinical Decision Making January 8, 2025
- Interpreting TDM Results – Interdisciplinary Collaboration for Optimized Drug Safety in Antipsychotic Therapy November 26, 2024
- Therapeutic Drug Monitoring in Psychiatry – Positive Impact on Patients through Lab-Clinician Collaboration September 27, 2024
- Clinical Impact and Outcomes Utilizing Antipsychotic TDM September 27, 2024
- Essential Antipsychotic Drug Level Monitoring July 8, 2024
- Guidance for Managing the Unexpectedly High or Low Clozapine Level July 8, 2024
-
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test June 5, 2024
